Seeking Alpha
Seeking Alpha Portfolio App for iPad
Finance
(1)
Market Currents

Threshold Pharmaceuticals (THLD) +6.3% premarket after earning a $30M milestone payment from...

  • Friday, January 25, 9:26 AM ET
    Threshold Pharmaceuticals (THLD) +6.3% premarket after earning a $30M milestone payment from drug partner Merck (MRK), which started a late-stage study of THLD's pancreatic cancer drug. TH-302 is an investigational hypoxia-targeted drug designed to be activated under severe tumor hypoxic conditions, a hallmark of many cancers.
Track new comments on this story

This news story has 1 comment:

  •  
    SA Editors - Merck KgA (MRK.DE), the German company, is partnered with THLD on TH-302, not MRK the US pharma.
    25 Jan, 10:52 AM Reply Like
LATEST|
TODAY SO FAR|
YESTERDAY
Other date
DJIA (DIA) S&P 500 (SPY)

HEALTHCARE ETFs IN FOCUS

Latest Healthcare Articles
More Latest Articles »